Effects of recombinant human growth hormone therapy on psychological behavior of children with idiopathic short stature

doi:10.11852/zgetbjzz2020-1695

journal1 ›› 2021, Vol. 29 ›› Issue (1): 71-74.DOI: 10.11852/zgetbjzz2020-1695

• Clinical Research • Previous Articles Next Articles

Effects of recombinant human growth hormone therapy on psychological behavior of children with idiopathic short stature

ZENG Pei-pei, HUANG Li-ping, DENG Liang-qiong, FENG Yu-shan, XIONG Li, ZENG Ting, LI Hong-hui

Liuzhou Maternity and Child Healthcare Hospital,the Affiliated Maternity Hospital and Affiliated Children's Hospital of Guangxi University of Science and Technology,Liuzhou,Guangxi 545001,China

Received:2020-09-10 Revised:2020-10-27 Online:2021-01-10 Published:2021-01-10
Contact: LI Hong-hui,E-mail: lzfyebzx@126.com

重组人生长激素治疗对特发性矮小症儿童心理状态影响的分析

曾佩佩, 黄丽萍, 邓梁琼, 冯玉山, 熊莉, 曾婷, 李红辉

柳州市妇幼保健院,广西科技大学附属妇产医院、儿童医院,广西柳州 545001

通讯作者: 李红辉,E-mail:lzfyebzx@126.com
作者简介:曾佩佩(1990-),女,广西人,住院医师,硕士研究生,主要研究方向为儿童发育行为疾病。
基金资助:
广西壮族自治区卫生和计划生育委员会自筹经费科研课题(Z20180009);柳州市科学研究与技术开发计划课题(2017BH20311);柳州市科学研究与技术开发计划课题(2017BD20201)

Abstract

Abstract: Objective To investigate the effect of recombinant human growth hormone therapy on the psychological behavior of children with idiopathic short stature (ISS),in order to provide reference for clinical treatment.Methods From January 2018 to December 2019,a total of 70 children with ISS treated in Liuzhou Maternity and Child Healthcare Hospital were randomly divided into treatment group and control group,with 35 cases in each group.The treatment group was given recombinant human growth hormone 0.15 IU/(kg·d) and injected subcutaneously before bedtime.Both groups received enhanced nutrient supplement,proper exercise,adequate sleep and good mood,and the treatment lasted for 6 months.After the treatment,the score of psychological behavior were compared between two groups.Results After treatment,the scores of split-like,hyperactivity,aggression,violation of discipline factors for boys,(t=4.465,5.053,7.064,5.804,6.815,5.112) body complaint and division forcing factor for girls (t=6.815,5.112) in the treatment group were lower than those before treatment(P<0.05).The scores of split-like,hyperactivity,aggression,violation of discipline factors for boys (t=-3.576,-2.551,-6.100,-2.859),body complaint,social retreat and division forcing factor for girls (t=-7.357,-5.036) in the treatment group were significantly lower than those in the control group after treatment (P<0.05).Conclusions Recombinant human growth hormone therapy can effectively improve some psychological and behavioral problems in ISS children.Recombinant human growth hormone therapy can make the physical and mental development of ISS children more stable and healthy,thus reducing the incidence of psychological and behavioral problems in ISS children.

Key words: recombinant human growth hormone, idiopathic short stature, psychological behavior

摘要： 目的分析重组人生长激素治疗对特发性矮小症(ISS)患儿心理行为的影响,为临床诊治提供参考依据。方法选择2018年1月—2019年12月在柳州市妇幼保健院儿童保健科就诊治疗的特发性矮小症患儿70例作为研究对象,随机分为治疗组和对照组,每组35例。治疗组给予重组人生长激素0.15 U/(kg·d),睡前皮下注射,两组均给予加强营养素补充,指导适当运动、充足的睡眠,保持心情愉悦,疗程均为6个月,观察两组患儿心理行为问题情况。结果治疗后治疗组男童分裂样、多动、攻击性、违纪因子得分及女童体诉、分裂强迫因子得分较治疗前下降(t=4.465、5.053、7.064、5.804、6.815、5.112,P＜0.05),治疗组男童分裂样、多动、攻击性、违纪因子得分及女童体诉及分裂强迫因子得分低于对照组(t=-3.576、-2.551、-6.100、-2.859、-7.357、5.036,P＜0.05)。结论重组人生长激素治疗能有效改善ISS儿童部分心理行为问题,给予重组人生长激素治疗能让ISS儿童身心发展更趋稳定和健康,从而降低其心理行为问题的发生率。

关键词: 重组人生长激素, 特发性矮小症, 心理行为

CLC Number:

R725.8

ZENG Pei-pei, HUANG Li-ping, DENG Liang-qiong, FENG Yu-shan, XIONG Li, ZENG Ting, LI Hong-hui. Effects of recombinant human growth hormone therapy on psychological behavior of children with idiopathic short stature[J]. journal1, 2021, 29(1): 71-74.

曾佩佩, 黄丽萍, 邓梁琼, 冯玉山, 熊莉, 曾婷, 李红辉. 重组人生长激素治疗对特发性矮小症儿童心理状态影响的分析[J]. 中国儿童保健杂志, 2021, 29(1): 71-74.

References

[1] 中华医学会儿科分会内分泌遗传代谢学组.矮身材儿童诊治指南[J].中华儿科杂志,2008,46(6):428-430.
[2] Bullinger M,Bloemeke J,Mericq V,et al.Quality of life in adolescent boys with idiopathic short stature:positive impact of growth hormone and aromatase inhibitors[J].Horm Res Paediatr,2018,90(6):381-392.
[3] Cohen LE.Idiopathic short stature:a clinical review[J].JAMA,2014,311(17):1787-1796.
[4] Noeker M.Psychological functioning in idiopathic short stature[J].Horm Res Paediatr,2011,76(3):52-56.
[5] 闫培培,杨玲玲,党晓丽.2015-2017年郑州某医院矮小症患儿焦虑抑郁状况调查[J].预防医学论坛,2019,25(1):39-41.
[6] 陈凌华,赵慧,张素珍,等.矮小症儿童主观生活质量和社会适应能力的研究[J].中国儿童保健杂志,2016,24(12):1271-1273.
[7] Cohen P,Rogol AD,Deal CL,et al.Consensus statement on the diagnosis and treatment of children with idiopath ic short stature:a summary of the Growth Hormone Research Society,the Lawson Wilkins Pediatric Endocrine Society,and the European Society for Paediatric Endocrinology Workshop[J].J Clin Endocrinol Metab,2008,93(11):4210-4217.
[8] 忻仁娥,张志雄,蔡小明,等.全国22个省市26个单位24013名城市在校儿童行为问题凋查—独生子女精神卫生问题的调查、防治和Achenbach's儿童行为量表中国标准化[J].上海精神医学,1992,4(1):47-55.
[9] 苏林燕,李雪荣,罗学荣.Achenbach 儿童行为量表的再标准化及效度检验[J].中国心理卫生杂志,1998,12(2):672-679.
[10] 刘芳,陈俐君,晏世玲.重组人生长激素治疗青春期早期特发性矮小症对骨代谢的影响[J].儿科药学杂志,2019,25(6):26-29.
[11] 沙玉龙.重组人生长激素治疗儿童矮小症的临床效果观察[J].中国冶金工业医学杂志,2020,37(2):204-205.
[12] 中华医学会儿科学分会内分泌遗传代谢学组,《中华儿科杂志》编辑委员会.基因重组人生长激素儿科临床规范应用的建议[J].中华儿科杂志,2013,51(6):426-431.
[13] 吴志华,钟世彪,韦茹,等.不同性别学龄儿童行为问题影响因素分析[J].广州医药,2017,48(1):85-86,91.
[14] 宁曼,何海燕,余敏.儿童心理行为问题及影响因素概述[J].中国妇幼卫生杂志,2017,8(3):4-6,11.
[15] 许露,肖延风,王亚萍,等.身材矮小儿童睡眠饮食和行为问题的病例对照研究[J].中国儿童保健杂志,2020,28(6):664-668.
[16] 朱锦渊,宋娟,农雪艳,等.特发性矮小对不同年龄阶段儿童心理行为的影响[J].中国医学创新,2015,12(23):36-39.

Effects of recombinant human growth hormone therapy on psychological behavior of children with idiopathic short stature

重组人生长激素治疗对特发性矮小症儿童心理状态影响的分析

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LIANG Yijia, WU Honglin, HE Xiumei, HU Xiaohong, HE Xiyu. Types and frequencies of gene variants in idiopathic short stature children [J]. Chinese Journal of Child Health Care, 2023, 31(6): 678-683.
[2]	ZHANG Qiang, LIU Li-jun, LI Jin-ying, CUI Hai-jing, WANG Yi-jing. Efficacy of rhGH combined with letrozole in the clinical treatment of adolescent idiopathic short stature in male children [J]. Chinese Journal of Child Health Care, 2021, 29(7): 802-805.
[3]	HE Hong-ling, LIU Yu-chen, ZHANG Da-wei, LI Na, MA Ming-fang, LIU Hui, YANG Lu, GAO Cheng-ge, HUANG Yan-ping. Study on changes for behavior problems of 4- to 6-year-old children in Xi'an in 2007 and 2018 [J]. journal1, 2021, 29(1): 79-83.
[4]	SHI Qian-ping, HUANG Ai-qun, PAN Xiao-ping. Analysis of the status quo and influencing factors of early warning screening of psychological behavior in infants aged 24 months [J]. journal1, 2020, 28(9): 1017-1020.
[5]	ZHANG Ling-li, HU Xiao-ping, WAN Xiao-xian, GUO Sheng-nan, LUO Zhen-zhou. Relationship between psychological behavior problems and parental health literacy in preschool children [J]. journal1, 2020, 28(5): 579-582.
[6]	TANG Xiu-ping, LI Ling, YAN Bao-rui. Effect of Caltrate D combined with recombinant human growth hormone on bone metabolization indexes and serum levels of IGF-1,25-(OH)D in children with idiopathic short stature [J]. journal1, 2019, 27(7): 729-732.
[7]	ZHANG Yang, HOU Wei. Research progress on psychological and behavioral problems in children with bronchial asthma [J]. journal1, 2019, 27(5): 523-526.
[8]	PENG Chun-yan, CHU Chang-shan, LIU Cheng-xian, GUO Lei. Investigation and analysis of 1 264 preschool children's psychological behavior problems in Liuan city,Anhui [J]. journal1, 2018, 26(7): 787-789.
[9]	PENG Yan, ZHANG Chong-jian, WANG Ying, HE Zhi-hong. Effects of polyethylene glycol recombinant growth hormone on serum p53 and p21waf / cip1 expression in children with idiopathic short stature [J]. journal1, 2018, 26(6): 587-589.
[10]	GUI Lin-yan, WANG Pu. Research on the dose of growth hormone in prepubertal children with idiopathic short stature [J]. journal1, 2018, 26(4): 451-452.
[11]	OU Wan-xing, WANG Ling-hua, CHA Cai-hui, YANG Si-yuan, QIU Tian-xiang. Analysis of psychological behaviors in children with selective mutism [J]. journal1, 2018, 26(10): 1137-1139.
[12]	LI Xin,BAN Bo,QIAO Jian-min,CHEN Han-wen,ZHENG Cheng-ran.. Meta-analysis on the association of the relativity of neoplasms and the effect of recombinant human growth hormone therapy in growth hormone deficiency. [J]. journal1, 2017, 25(1): 55-58.
[13]	ZHENG Cheng-ran,BAN Bo,ZHANG Mei,SUN Hai-ling,LI Ping,WANG Na,SHAO Qian.. Effect of rhGH on thyroid function and its clinical significance in children with growth hormone deficiency. [J]. journal1, 2016, 24(6): 616-618.
[14]	YOU Jia,WANG Su-qing,WANG Jin,YANG Xiao-yan,WU Jun-ya.. Supervision on the neuropsychological behavior development of children with preterm and low birth weight. [J]. journal1, 2016, 24(6): 662-664.
[15]	PAN Xiao-fen,LEI Xin-yan,LIN Guo-mo,LIU Yu-ling,DENG Cheng.. Study on the psychological behavior and related factors of primary enuresis children aged 6 to 11. [J]. journal1, 2016, 24(5): 525-527.